Brief: Xspray Pharma Gets CRL From FDA For Dasynoc
19/08/2026 06:40
BRIEF-Xspray Pharma Gets CRL From FDA For Dasynoc Aug 19 (Reuters) - Xspray Pharma publ AB XSPRAY.ST:
RECEIVES COMPLETE RESPONSE LETTER (CRL) FROM FDA FOR DASYNOC
Source text: ID:nMFN25nrw5
Further company coverage: XSPRAY.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))